Increased expression of CD39 in combination with CD103 has already been described as a phenotypic signature for tumor antigen-specific CD8+ T cells [24,44], hypothesizing that γδ T cells in the tumor carry a similar immune signature as CD8+ T cells. This evidence concerns the gene ENTPD1 and neoplasm.